Blood glucose limits

Insulin, a hormone produced by the pancreas, acts to maintain blood glucose levels within normal limits (60-120 mg/dL). This is accomplished by die release of small amounts of insulin into die bloodstream tiirough-out the day in response to changes in blood glucose levels. Insulin is essential for die utilization of glucose in cellular metabolism and for die proper metabolism of protein and fat. 

THE CONCENTRATION OF BLOOD GLUCOSE IS REGULATED WITHIN NARROW LIMITS... 

Exanatide is available in 5 and 10 meg injectible prehlled disposable pens. Initial therapy is 5 meg twice daily, injected before the two largest meals of the day. Meals should be separated by at least 5 to 6 hours. Doses then are increased after a month to 10 meg if the patient s blood glucose is improving and nausea is limited. Exanatide can be given up to 60 minutes before a meal, but practical use indicates that injection just before a meal may decrease nausea. An average weight loss of 3 to 5 pounds (1.36-2.27 kg) commonly occurs with the 5 meg dose, whereas a weight loss of 5 to 10 pounds (2.27-4.55 kg) is observed with the 10 meg dose. 

Electrolytes and renal function are within normal limits. Fasting blood glucose level is 206 mg/dL (11.43 mmol/L), HbA1c is 8.5%, and (-) microalbumin. GH level following an oral glucose tolerance test is 8 ng/mL (8 mcg/L). Elevated IGF-I at 790 ng/mL (790 mcg/L)... 

Physiology is the study of the functions of the human body. In other words, the mechanisms by which the various organs and tissues carry out their specific activities are considered. Emphasis is often placed on the processes that control and regulate these functions. In order for the body to function optimally, conditions within the body, referred to as the internal environment, must be very carefully regulated. Therefore, many important variables, such as body temperature, blood pressure, blood glucose, oxygen and carbon dioxide content of the blood, as well as electrolyte balance, are actively maintained within narrow physiological limits. 

Since the enzyme glycogen synthase catalyses the rate-limiting step in glycogen synthesis, it is the activity of this enzyme that must be increased as the blood glucose concentration increases. This is achieved via an interconversion cycle (i.e. reversible phosphorylation). A protein kinase phosphorylates it, which inactivates the enzyme, whereas a protein phosphatase dephosphorylates it, which... 

Fatty acids require about 7% more oxygen than does carbohydrate to generate the same amount of ATP. Under circumstances where oxygen supply is limiting, for example in parts of the myocardium after an occlusion in one of the arteries, glucose is the preferred fuel and attempts are made to increase blood glucose levels and decrease mobilisation of fatty acids in this condition (see Chapter 22). 

Avandia contains rosiglitazone, which is a thiazolidinedione that is used as oral antidiabetic therapy. Thiazolidinediones reduce peripheral insulin resistance, resulting in reductions in blood-glucose concentrations. Inadequate response to oral antidiabetic therapy indicates failing insulin release and the impact of the introduction of rosiglitazone is of limited benefit on patient outcomes. Insulin should be considered. 

One question that is often asked of statisticians is in what sense can we be 95% confident that the population mean lies within the limits 3.84 and 4.13 To answer the question we can again conduct a sampling experiment as follows. Suppose that the 40 blood glucose measurements in Figure 8.3 comprised the total population of values. For random sample of size 10 from the populations of blood glucose values determine the sample mean, standard error and the corresponding 95% confidence interval. Repeat the process 100 times. The results of such an experiment are shown in Figure 8.6. 

The closed-loop type artificial pancreas (specifically 8-cell), which consists of an automatic continuous monitor of blood glucose level (BGL) and an automatic injector of insulin which are coupled with feed-back system, has great potential for prevention of diabetic complication such as micro-angiopathies(l). A large-scale closed-loop type artificial pancreas for bedside use has already been developed and is clinically used at some laboratories and hospitals (2-4). However, this device is limited to only bedside use. On the other hand, the open-loop type artificial pancreas which consists of only a insulin injecting pump without an automatic continuous monitor of BGL, has been developed and is going to be clinically used(5-7). This system, however, can not completely control BGL as well as the bare pancreas in a normal body and often causes lower BGL(8-9). 

---